Giant renal angiomyolipoma: a rare presentation
DOI:
https://doi.org/10.35954/SM2019.38.2.7Keywords:
Angiomyolipoma; NephrectomyAbstract
Renal angiomyolipoma is a benign tumor of incidental ultrasound finding in 60% of cases. The study with Computed Tomography or Magnetic Resonance makes diagnosis by the presence of intratumoral fat. The increased vascular calibre distinguishes it in liposarcoma tomography, differential diagnosis when the angiomyolipoma is large. According to its volume, control is defined with observation or active treatment to avoid the main complication: spontaneous hemorrhage that occurs in 50-60% of cases, and can be serious. The objective is to eliminate the tumor with the least morbidity while preserving renal function. There are several options to select according to the size of the tumor, and the current renal function or with risk of alteration: total nephrectomy; nephrone-preserving nephrectomyby robotic surgery is another conservative alternative in development; selective embolization of branches of the renal artery or techniques of tissue ablation (cryoablation, radiofrequency); laparoscopic partial nephrectomy has results comparable to radical surgery.
We present the clinical case of a patient with a giant renal angiomyolipoma and its surgical resolution.
Downloads
References
(1) Pedemonte JG, Degiovanni D, Pusterla D, Reibel C, Di Nucci J, Boccio C, et al. Tríada de Lenk como presentación clínica del angiomiolipoma. Actas Urol Esp 2008; 32(8):850-854.
(2) Bestard Vallejo JE, Trilla Herrera E, Celma Domenech A, Pérez Lafuente M, de Torres Ramírez I, Morote Robles J. Angiomiolipomas renales: presentación, tratamiento y resultado de 20 casos. Actas Urol Esp 2008; 32(3):307-315.
(3) Bissler JJ, Kingswood JC. Renal angiomyolipomata. Kidney Int 2004; 66(3):924-934. doi: 10.1111/j.1523-1755.2004.00838.x
(4) Henske EP, Ao X, Short MP, Greenberg R, Neumann HP, Kwiatkowski DJ, et al. Frequent progesterone receptor immunoreactivity in tuberous sclerosis-associated renal angiomyolipomas. Mod Pathol 1998; 11(7):665-668.
(5) Sooriakumaran P, Gibbs P, Coughlin G, Attard V, Elmslie F, Kingswood C, et al. Angiomyolipomata: challenges, solutions, and future prospects based on over 100 cases treated. BJU Int 2010; 105(1):101-6. doi: 10.1111/j.1464-410X.2009.08649.x
(6) Iriarte Soldevilla J, Senarriaga Ruiz de la Illa N, Lacasa Viscasillas I, Loizaga Iriarte A, Zubiaur Libano C, Unda Urzaiz M. Tratamiento actual de las masas renales pequeñas. Actas Urol Esp 2009; 33(5):505-51.
(7) Castillo O, Fonerón A, Vidal I, Tapia C. Nefrectomía parcial laparoscópica en angiomiolipoma gigante. Rev Chil Cir 2008; 60(5):442-446. doi: 10.4067/S0718-40262008000500014
(8) Lin CY, Yang CK, Ou YC, Chiu KY, Cheng CL, Ho HC. Long-term outcome of robotic partial nephrectomy for renal angiomyolipoma. Asian J Surg 2018; 41(2):187-191. doi: 10.1016/j.asjsur.2016.11.003
(9) El-Hashemite N, Walker V, Zhang H, Kwiatkowski DJ. Loss of Tsc1 or Tsc2 induces vascular endothelial growth factor production through mammalian target of rapamycin. Cancer Res 2003; 63(17):5173-7.
Published
How to Cite
Issue
Section
License
Until 2024 we use the Creative Commons Attribution/NonCommercial Attribution 4.0 International License https://creativecommons.org/licenses/by-nc/4.0/deed.es. Which states that: you are free to share, copy and redistribute the material in any medium or format, as well as to adapt, remix, transform and build upon the material. Under the following terms:
Attribution: you must give proper credit , provide a link to the license, and indicate if changes have been made . You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
NonCommercial: you may not use the material for commercial purposes.
As of 2025 authors retain their copyright and assign to the journal the right of first publication of their work, which shall simultaneously be subject to the license https://creativecommons.org/licenses/by-nc-sa/4.0/deed.es that permits sharing, copying and redistribution of the material in any medium or format provided that initial publication in this journal is indicated. Adapt, remix, transform and build upon the material. If you remix, transform, or build from the material, you must distribute your contribution under the same license as the original and may not make use of the material for commercial purposes.
Under the following terms:
1. Attribution: you must give proper credit, provide a link to the license, and indicate whether changes have been made. You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
2. NonCommercial: you may not use the material for commercial purposes.
3. ShareAlike: if you remix, transform or build upon the material, you must distribute your contribution under the same license as the original.
PlumX Metrics
/
